Current instructor

Leslie Dickmann

What students say

Original student reviews · all captured dates

No unambiguous review-profile match is available.

Personal experiences, not a representative survey. Profile matching and captured coverage are shown in the source details.

Classes with Leslie Dickmann

PHMSCI 755

Laboratory and Instrumentation Methods

3 credits

Covers laboratory techniques and analytical instrumentation for drug discovery, including DNA, chromatography, cell culture, protein analysis, and mass spectrometry.

Offering recorded · Spring 2027 · Sources

Recent recorded grades — Spring 2024: 3.89 GPA, 92.9% A/AB (n=14 letter grades); Spring 2025: 3.95 GPA, 100.0% A/AB (n=10 letter grades); Spring 2026: 3.88 GPA, 91.7% A/AB (n=12 letter grades). Includes jointly taught sections.

Beth RosenLeslie Dickmann

historical GPA · grades

Spring 2024–Spring 2026 · limited sample
PHMSCI 759

Current Trends in Drug Discovery and Development

1 credits

Current trends in drug discovery and development focusing on finding, reading, and critically analyzing scientific and regulatory literature.

Offering recorded · Spring 2027 · Sources

Recent recorded grades — Spring 2025: 3.86 GPA, 93.1% A/AB (n=29 letter grades); Fall 2025: 3.63 GPA, 89.5% A/AB (n=19 letter grades); Spring 2026: 3.85 GPA, 92.3% A/AB (n=26 letter grades).

Leslie Dickmann

historical GPA · grades

Fall 2022–Spring 2026
PHMSCI 762

The Drug Development Process From Discovery to Investigational New Drug Application (ind)

3 credits

Overview of drug development from discovery to IND, covering target identification, validation, hit-to-lead, CMC, pharmacology, pharmacokinetics, and toxicology for small and large molecules.

Offering recorded · Spring 2027 · Sources

Recent recorded grades — Fall 2024: 3.44 GPA, 67.7% A/AB (n=31 letter grades); Fall 2025: 3.39 GPA, 78.3% A/AB (n=23 letter grades); Spring 2026: 3.83 GPA, 100.0% A/AB (n=6 letter grades). Includes jointly taught sections.

Ardala KatzfussLeslie Dickmann

historical GPA · grades

Fall 2023–Spring 2026 · limited sample
PHMSCI 763

The Drug Development Process From Fih to Bla/nda

3 credits

Overview of drug development from first-in-human to NDA/BLA submission, covering clinical phases, biomarkers, companion diagnostics, statistical analysis, CMC, and both small molecule and protein therapeutics.

Offering recorded · Spring 2027 · Sources

Recent recorded grades — Fall 2024: 3.89 GPA, 100.0% A/AB (n=9 letter grades); Spring 2025: 3.75 GPA, 92.9% A/AB (n=28 letter grades); Spring 2026: 3.93 GPA, 100.0% A/AB (n=27 letter grades).

Leslie Dickmann

historical GPA · grades

Spring 2024–Spring 2026 · limited sample

Recorded teaching history

Distinct courses recorded per term

Explore courses taught by this instructor →
Browse recorded courses
TermCourseTitle
Spring 2027PHMSCI 755Laboratory and Instrumentation Methods
Spring 2027PHMSCI 759Current Trends in Drug Discovery and Development
Spring 2027PHMSCI 762The Drug Development Process From Discovery to Investigational New Drug Application (ind)
Spring 2027PHMSCI 763The Drug Development Process From Fih to Bla/nda
Fall 2026PHMSCI 558Laboratory Techniques in Pharmacology and Toxicology
Fall 2026PHMSCI 699Advanced Independent Study
Fall 2026PHMSCI 757Introduction to Drug Development
Fall 2026PHMSCI 759Current Trends in Drug Discovery and Development
Fall 2026PHMSCI 762The Drug Development Process From Discovery to Investigational New Drug Application (ind)
Fall 2026PHMSCI 764Case Studies in Drug Development

Teaching history may be incomplete. Course pages contain course-specific feedback and citations.

Instructor identity & provenance 
{
  "instructor_uid": "instructor_3aea62525aeb86c5fbe4025b",
  "source": "enrollment",
  "source_instructor_id": "ljdickmann",
  "identity_basis": "netid",
  "identity_status": "source_identified",
  "name": "Leslie Dickmann",
  "email": "LJDICKMANN@WISC.EDU",
  "first_observed_at": "2026-09-07 15:55:43.033547+00:00",
  "last_observed_at": "2026-10-14 17:50:09.728220+00:00",
  "current": true,
  "courses": [
    {
      "course_uid": "course_01d4aba10ddd2d6531ccd4d2",
      "course_id": "PHMSCI 755",
      "title": "LABORATORY AND INSTRUMENTATION METHODS",
      "credits_min": 3,
      "credits_max": 3,
      "gpa": 3.918
    },
    {
      "course_uid": "course_1d5bb2f15f5fd3f6e4e8f809",
      "course_id": "PHMSCI 762",
      "title": "THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)",
      "credits_min": 3,
      "credits_max": 3,
      "gpa": 3.506
    },
    {
      "course_uid": "course_5e5cc5e4d991719530249935",
      "course_id": "PHMSCI 759",
      "title": "CURRENT TRENDS IN DRUG DISCOVERY AND DEVELOPMENT",
      "credits_min": 1,
      "credits_max": 1,
      "gpa": 3.79
    },
    {
      "course_uid": "course_b7da72aecf53dbf40a363e61",
      "course_id": "PHMSCI 763",
      "title": "THE DRUG DEVELOPMENT PROCESS FROM FIH TO BLA/NDA",
      "credits_min": 3,
      "credits_max": 3,
      "gpa": 3.809
    }
  ],
  "revision": "fc1811fa52e581ea57a35c0cf3343f8740a8ffbf",
  "instructor_url": "/instructors/LESLIE_DICKMANN"
}